Peculiarities of vaginal microbiota in perimenopausal and postmenopausal women with type 2 diabetes mellitusOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study investigated how type 2 diabetes mellitus (T2DM) affects the vaginal microbiota in perimenopausal and postmenopausal women. Researchers used metagenomic sequencing of vaginal secretion samples to characterize microbial community structure and functional homeostasis. They assessed alpha diversity (Observe, ACE, Shannon-Weaver, Gini-Simpson indices) and beta diversity (PCoA, NMDS), and applied taxonomic profiling, LEfSe analysis, co-occurrence network construction, and neutral community modeling to determine whether stochastic or deterministic processes shaped the community.
Who was studied?
The study included 22 women with T2DM (the DM group) and 23 healthy women (the CT group), all in perimenopausal or postmenopausal life stages. The two groups did not differ significantly in age (62.22 plus or minus 5.74 years vs. 58.23 plus or minus 7.55 years, p = 0.052) or in the proportion of perimenopausal versus postmenopausal participants (3/19 vs. 5/18, p = 0.748). This design allowed the researchers to isolate the effect of T2DM on the vaginal microbiota independent of age or menopausal status.
What were the most important findings?
The DM group showed significantly higher alpha diversity than the control group (p < 0.05), along with distinct clustering on beta diversity analysis (p < 0.05). This shift was marked by reduced Lactobacillus abundance in the diabetic women compared to healthy controls. The abstract indicates additional taxonomic and network-level differences were identified through LEfSe and co-occurrence analyses, alongside evidence bearing on stochastic versus deterministic community assembly, though the abstract text provided does not detail every specific taxon or network finding beyond the Lactobacillus reduction.
What are the greatest implications of this study?
The findings suggest that T2DM is associated with a less Lactobacillus-dominated, more diverse and heterogeneous vaginal microbial community in perimenopausal and postmenopausal women, independent of age or menopausal stage. Since a Lactobacillus-depleted vaginal environment is generally linked to reduced protective function, this points to T2DM as a distinct driver of vaginal dysbiosis risk in this population. These results underscore the need to consider metabolic status, not just menopause, when evaluating vaginal microbiome health and potential dysbiosis-adjustment strategies in aging women.